Alternative agents in asthma
Summary
This summary is machine-generated.Managing difficult asthma involves exploring steroid-sparing treatments beyond inhaled glucocorticosteroids. New agents target inflammation, offering hope for patients with severe or steroid-intolerant asthma.
Area Of Science
- Pulmonology
- Immunology
- Pharmacology
Background
- Glucocorticosteroids are primary inhaled asthma treatments.
- Difficult asthma patients are heterogeneous, including those with side effects or instability on high-dose steroids.
- Current treatments have limitations for managing severe asthma.
Purpose Of The Study
- To review steroid-sparing and alternative agents for difficult asthma.
- To discuss the efficacy and limitations of current and emerging therapies.
- To explore future directions in difficult asthma management.
Main Methods
- Review of existing literature on asthma pharmacotherapy.
- Analysis of conventional immunosuppressants, leukotriene receptor antagonists, and novel targeted agents.
- Discussion of emerging therapeutic strategies.
Main Results
- Conventional immunosuppressants (methotrexate, gold, cyclosporin A) have limited application.
- Leukotriene receptor antagonists offer modest steroid-sparing effects.
- New agents targeting IgE, cytokines, chemokines, and adhesion molecules show promise.
- Future strategies may include immunotherapy and airway remodeling interventions.
Conclusions
- No single alternative agent has proven highly effective for all difficult asthma cases.
- Targeted therapies represent a significant advancement in managing severe asthma.
- Future research should focus on immunotherapy and airway remodeling for improved patient outcomes.
View abstract on PubMed